Editas Medicine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). 

CEO
Gilmore O’Neill
CEOGilmore O’Neill
Employees
246
Employees246
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
246
Employees246

EDIT Key Statistics

Market cap
334.05M
Market cap334.05M
Price-Earnings ratio
-1.30
Price-Earnings ratio-1.30
Dividend yield
Dividend yield
Average volume
3.64M
Average volume3.64M
High today
$4.34
High today$4.34
Low today
$3.60
Low today$3.60
Open price
$4.19
Open price$4.19
Volume
3.53M
Volume3.53M
52 Week high
$4.54
52 Week high$4.54
52 Week low
$0.9101
52 Week low$0.9101

EDIT News

TipRanks 2d
Editas Medicine Unveils Promising Preclinical Data on EDIT-401

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 2d
Editas Medicine reports in vivo preclinical PoC data for EDIT-401

Editas Medicine (EDIT) reported in vivo preclinical proof-of-concept data for EDIT-401, an experimental, one-time therapy to significantly reduce LDL-cholestero...

Simply Wall St 5d
While institutions invested in Editas Medicine, Inc. benefited from last week's 11% gain, individual investors stood to gain the most

Advertisement Key Insights The considerable ownership by individual investors in Editas Medicine indicates that they collectively have a greater say in manage...

While institutions invested in Editas Medicine, Inc. benefited from last week's 11% gain, individual investors stood to gain the most

Analyst ratings

43%

of 14 ratings
Buy
42.9%
Hold
42.9%
Sell
14.3%

People also own

Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.